OMNIAB, INC. Variable Lease, Cost
OMNIAB, INC. (OABI) reported Variable Lease, Cost of $369.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2026-08-06
- OMNIAB, INC. variable lease, cost for the quarter ending 2026-06-30 was $369.00K, a 13.99% decline year-over-year.
- OMNIAB, INC. variable lease, cost for the quarter ending 2026-03-31 was $313.00K, a 25.20% increase year-over-year.
- OMNIAB, INC. variable lease, cost for the quarter ending 2025-12-31 was $428.00K, a 7.16% decline year-over-year.
- OMNIAB, INC. variable lease, cost for the quarter ending 2025-09-30 was $427.00K, a 17.73% decline year-over-year.
- OMNIAB, INC. variable lease, cost for fiscal 2025 was $1.53M, a 14.68% decline from fiscal 2024.
- OMNIAB, INC. variable lease, cost for fiscal 2024 was $1.80M, a 17.98% increase from fiscal 2023.
- OMNIAB, INC. variable lease, cost for fiscal 2023 was $1.52M, a 18.97% increase from fiscal 2022.
- OMNIAB, INC. variable lease, cost for fiscal 2022 was $1.28M, a 114.57% increase from fiscal 2021.
| Period end | Variable Lease, Cost 3 month | Variable Lease, Cost 6 month | Variable Lease, Cost 9 month | Variable Lease, Cost 12 month |
|---|---|---|---|---|
| 2026-06-30 | $369.00K 10-Q · filed 2026-08-06 | $682.00K 10-Q · filed 2026-08-06 | $1.11M derived: sum of 3 quarters · filed 2026-08-06 | $1.54M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $313.00K 10-Q · filed 2026-05-07 | $741.00K derived: sum of 2 quarters · filed 2026-05-07 | $1.17M derived: sum of 3 quarters · filed 2026-05-07 | $1.60M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $428.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $855.00K derived: sum of 2 quarters · filed 2026-03-04 | $1.28M derived: sum of 3 quarters · filed 2026-08-06 | $1.53M 10-K · filed 2026-03-04 |
| 2025-09-30 | $427.00K 10-Q · filed 2025-11-04 | $856.00K derived: sum of 2 quarters · filed 2026-08-06 | $1.11M 10-Q · filed 2025-11-04 | $1.57M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $429.00K 10-Q · filed 2026-08-06 | $679.00K 10-Q · filed 2026-08-06 | $1.14M derived: sum of 3 quarters · filed 2026-08-06 | $1.66M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $250.00K 10-Q · filed 2026-05-07 | $711.00K derived: sum of 2 quarters · filed 2026-05-07 | $1.23M derived: sum of 3 quarters · filed 2026-05-07 | $1.67M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $461.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $980.00K derived: sum of 2 quarters · filed 2026-03-04 | $1.42M derived: sum of 3 quarters · filed 2026-03-04 | $1.80M 10-K · filed 2026-03-04 |
| 2024-09-30 | $519.00K 10-Q · filed 2025-11-04 | $956.00K derived: sum of 2 quarters · filed 2025-11-04 | $1.34M 10-Q · filed 2025-11-04 | $1.79M derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | $437.00K 10-Q · filed 2025-08-06 | $818.00K 10-Q · filed 2025-08-06 | $1.27M derived: sum of 3 quarters · filed 2025-08-06 | $1.64M derived: sum of 4 quarters · filed 2025-08-06 |
| 2024-03-31 | $381.00K 10-Q · filed 2025-05-08 | $835.00K derived: sum of 2 quarters · filed 2025-05-08 | $1.20M derived: sum of 3 quarters · filed 2025-05-08 | $1.54M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $454.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $818.00K derived: sum of 2 quarters · filed 2025-03-18 | $1.16M derived: sum of 3 quarters · filed 2025-03-18 | $1.52M 10-K · filed 2025-03-18 |
| 2023-09-30 | $364.00K 10-Q · filed 2024-11-12 | $709.00K derived: sum of 2 quarters · filed 2024-11-12 | $1.07M 10-Q · filed 2024-11-12 | $1.33M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $345.00K 10-Q · filed 2024-08-08 | $680.00K 10-Q · filed 2024-08-08 | $966.00K derived: sum of 3 quarters · filed 2024-08-08 | $1.41M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $335.00K 10-Q · filed 2024-05-09 | $621.00K derived: sum of 2 quarters · filed 2024-05-09 | $1.07M derived: sum of 3 quarters · filed 2024-05-09 | $1.42M derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $286.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $733.00K derived: sum of 2 quarters · filed 2024-03-25 | $1.08M derived: sum of 3 quarters · filed 2024-03-25 | $1.28M 10-K · filed 2024-03-25 |
| 2022-09-30 | $447.00K 10-Q · filed 2023-11-09 | $799.00K derived: sum of 2 quarters · filed 2023-11-09 | $995.00K 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $352.00K 10-Q · filed 2023-08-10 | $548.00K 10-Q · filed 2023-08-10 | ||
| 2022-03-31 | $196.00K 10-Q · filed 2023-05-11 | |||
| 2021-12-31 | $597.00K 10-K · filed 2023-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |